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The skin secretions of amphibians are rich in host defence peptides. The membrane interactions of the antimicrobial peptides, aurein 1.2,
citropin 1.1 and maculatin 1.1, isolated from Australian tree frogs, are reviewed. Although all three peptides are amphipathic α-helices, the mode
of action of these membrane-active peptides is not defined. The peptides have a net positive charge and range in length from 13 to 21 residues,
with the longest, maculatin 1.1, having a proline at position 15. Interestingly, alanine substitution at Pro-15 leads to loss of activity. The effects of
these peptides on phospholipid bilayers indicate different mechanisms for pore formation and lysis of model membranes, with the shorter peptides
exhibiting a carpet-like mechanism and the longest peptide forming pores in phospholipid bilayer membranes.
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Host defence peptides are known to protect amphibians
against a variety of pathogens [1]. The skin secretions of
Australian tree frogs are rich in anti-bacterial peptides [2]. In
order to exert their bioactive effects, the peptides must penetrate
the cell membrane and the means by which they destroy
bacteria is possibly by membrane lysis. The membrane
interactions of peptides from Australian tree frogs have been
studied, in particular, maculatin 1.1, citropin 1.1 and aurein 1.2;
and also the peptides caerin 4.1 and caerin 1.1 but to a lesser⁎ Corresponding author. Tel.: +61 3 8344 2447; fax: +61 3 9347 5180.
E-mail address: fs@unimelb.edu.au (F. Separovic).
0005-2736/$ - see front matter © 2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2006.02.010extent. The amino acid sequences of these peptides [3–6] are
given in Table 1.
The focus of this review is the antibacterial effect of these
peptides. However, the peptides are known to demonstrate other
bioactivity, including e.g. anti-cancer (aurein 1.2, caerin 1.1,
citropin 1.1, maculatin 1.1) and both fungicidal and specific
neuronal nitric oxide synthase inhibition (caerin 1.1, citropin
1.1, maculatin 1.1) [2]. Four of the peptides demonstrate anti-
bacterial activity against both Gram-positive and Gram-
negative species. The remaining peptide, caerin 4.1, shows a
more specific range of antibacterial effect, preferentially lysing
Gram-negative bacteria, including Pasteurella haemolytica,
which causes swine fever. The antibacterial effects of the
peptides are listed in Table 2.
Table 1
Amino acid sequence of selected antibacterial peptides from Australian tree
frogs




GLFDIIKKIAESF-NH2 1478 13 +1
Caerin
1.1 [4]
GLLSVLGSVAKHVLPHVVPVIAEHL-NH2 2582 25 +3
Caerin
4.1
GLWQKIKSAAGDLASGIVEGIKS-NH2 2326 23 +4
Citropin
1.1 [5 ]
GLFDVIKKVASVIGGL-NH2 1613 16 +2
Maculatin
1.1 [6]
GLFGVLAKVAAHVVPAIAEHF-NH2 2145 21 +3
Table 2











Bacillus cereus 50 50 – 50 25
Leuconostoc
lactis
6 1.5 – 6 3
Listeria
innocua
6 25 – 25 100
Micrococcus
luteus
100 12 12 12 12
Staphylococcus
aureus
– 3 – 25 6
Staphylococcus
epidermidis
50 12 – 12 12
Streptococcus
uberis
100 12 – 25 3
Escherichia
coli a
– – 25 – –
Pasteurella
multocida a
– 25 – – 50
Minimum inhibitory concentration (μg/mL).
a Gram negative bacteria.
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as inactive three part peptides: a signal peptide, a spacer peptide
and the anti-bacterial peptide. After synthesis the peptides are
transported to storage glands on the dorsal surface of the animal,
where the signal peptide is cleaved by an endopeptidase. The
resulting spacer-active peptide combination does not exhibit
antibacterial effect. Upon appropriate stimulation, the spacer
peptide is cleaved by a second endopeptidase and the active
peptide is secreted onto the dorsal surface of the amphibian [7].
The peptides are deactivated by a third endopeptidase,
deactivation occurring between 5–30 min after secretion
depending upon the species of frog [8]. The enzymes appear
to be membrane proteins [8] and deactivate these membrane-
active peptides by removal of residues from the N-terminus [5].
The peptides, many of which have major wide-spectrum
antibacterial properties, are expressed in the skin secretions
when the frog is stressed.
2. Common structural motifs
The peptides discussed in this study consist of between 13
(aurein 1.2) and 25 (caerin 1.1) amino acid residues. Each of the
peptides are cationic around neutral pH, with a net positive
charge between +1 (aurein 1.2) and +4 (caerin 1.1). Features
common to these peptides include a tendency towards random
coil arrangement in aqueous solution and an α-helical structure
in membrane mimetic environments [3–6]. The helixes are
amphipathic with polar side chains aligning along one face of
the α-helix.
The primary structures of the peptides have several notable
features. The N-terminus of each peptide consists of two
common residues, glycine and leucine. Aurein 1.2, citropin 1.1
and maculatin 1.1 share a third common N-terminal amino
acid, phenylalanine. Three of the peptides share the motif of
adjacent basic amino acids that are essential for anti-bacterial
activity [2]. Aurein 1.2 and citropin 1.1 contain lysine residues
at positions 7 and 8, while caerin 1.1 contains a lysine–
histidine arrangement at positions 11 and 12. Maculatin 1.1
does not contain adjacent basic amino acids, but does have a
lysine residue at position 8. Each of the peptides is also C-
terminal aminated and, again, this functional group is essential
for anti-bacterial action [9].These peptides may be divided into two groups based upon
peptide length and conformation when in membrane mimetic
environments. The shorter peptides aurein and citropin both
adopt a single continuous α-helix upon membrane binding. The
longer peptides comprise a flexible hinge region separating two
α-helices. Maculatin 1.1 contains one proline residue while
caerin 1.1 has two proline residues, which act to form a hinge
region [6,10]. The presence of the proline residue is known to
modulate the efficacy of maculatin 1.1 [11] and caerin 1.1. [12].
The region of conformational flexibility of caerin 4.1, on the
other hand, contains two glycine residues [13].
3. Models of peptide interaction with lipid membranes
Two principal modes of action for membrane-perturbing
peptides have been proposed: pore formation across the lipid
bilayer or a ‘carpet’ mechanism, lysing the membrane in a
detergent-like manner [14]. The transmembrane models involve
the peptides forming pores through the bacterial outer mem-
brane: the ‘barrel-stave’ [15] and toroidal pore [16,17] mechan-
isms. In these models, the peptides oligomerize to form pores
through the membrane. The pores act as non-selective channels
for ions, toxins and metabolites, thus preventing the bacterium
from maintaining homeostasis. Peptides with 20 or more amino
acids lend themselves to these mechanisms, as they are able to
span the lipid bilayer when in an α-helical conformation.
A key difference between these two mechanisms is the
positioning of the head group region of the lipid molecules with
respect to the peptide. In the barrel-stave mechanism, the
headgroups remain located along the membrane surface, while
the pore is formed by the interaction of the peptide within the
hydrophobic core of the membrane. The transmembrane pore is
lined by the hydrophilic surface of the peptide. By contrast,
toroidal pores are formed when the peptides insert in such a way
as to cause the inner and outer membrane leaflets to curve and
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interspersed by the phospholipid headgroups [15]. Preference
for barrel-stave vs. toroidal pore may depend on several factors
including the peptide length and membrane thinning effect
induced by the peptide [15,18]. The α-helical peptide, melittin,
the toxin in bee venom, has been shown by solid-state NMR to
adopt a transbilayer orientation in aligned phospholipid bilayers
[19]. Under similar conditions, melittin appears to form a
toroidal pore [15] and, interestingly, the peptide rotates about the
helical axis in fluid phase bilayers and this long axis rotation is
stopped when the lipid is in the gel phase [19]. Peptides that lyse
cells via a pore forming mechanism are predicted to be aligned
perpendicular to the membrane surface at high peptide
concentrations [18]. Moreover, these transmembrane mechan-
isms would not solubilize the lipids into smaller (and thus faster
tumbling) aggregates.
Alternatively, peptides may lie along the membrane surface
before disrupting the bilayer in a detergent like manner. After a
threshold concentration of peptides is reached, the peptides
permeate the membrane leading to disintegration. In this model,
lipids are solubilized by the proteins to form mixed micelles,
which could give an isotropic 31P NMR spectral component.
This mechanism of membrane perturbation is known as the
‘carpet’ model [20,21], although it has been suggested this
model is simply an extreme form of the toroidal pore model
[22]. In the case of the carpet mechanism, the cell membrane is
destabilized while for the pore-forming models more gradual
leakage would be expected. Upon cell lysis, a random
orientation with respect to the bilayer is expected for peptides
that cause membrane disruption via the carpet mechanism.
Several experimental techniques have been used in order to
determine which of these mechanisms are demonstrated by
antibacterial peptides. In the case of the peptides from
Australian tree frogs, solid-state NMR, circular dichroism
(CD), attenuated total reflectance-Fourier transform infrared
spectroscopy (ATR-FTIR), fluorescence imaging and Lang-
muir–Blodgett studies of monolayer collapse, have been
utilised. The complementary data from these methods allows
us to gain a multifaceted insight into the mode of action of these
antibacterial peptides.
4. Antibacterial effect—an NMR study
As noted above, several peptides isolated from amphibian
skin secretions exhibit broad-spectrum antibacterial activity. A
range of experiments has shown that the antibacterial effect of
these peptides is caused by lysing the bacterial membrane rather
than specific inhibition of a critical enzyme or receptor. Most
significantly, Chia et al. have shown that maculatin 1.1
synthesised from all D-amino acids has equivalent activity to
the naturally occurring peptide consisting of all L-isomers [6],
i.e. chirality has no influence on the activity of the peptide.
Moreover, 31P solid-state NMR spectroscopy of live Gram-
positive bacteria showed that inoculation with maculatin 1.1 or
caerin 1.1 causes a loss of integrity of the bacterial membrane
resulting in an isotropic signal (although some residual
anisotropic character remained) [23]. The change in the 31Pspectra was interpreted as showing that the bacterial membranes
were lysed and resulted in the formation of micelle-like
structures. By the same token, as expected, the narrow spectrum
antibacterial peptide caerin 4.1 (Table 2) did not appear to cause
disruption of the Gram positive bacteria Bacillus cereus and
Staphylococcus epidermidis used in the same study. Although
these experiments indicate that maculatin 1.1 and caerin 1.1 may
operate via the carpet model, due to the increase in isotropic
signal of the 31P NMR spectra, studies in model phospholipid
membranes suggest a pore-forming mechanism [24]. Electron
microscopy results show that maculatin 1.1 severely disinte-
grates cells of S. aureus [6,9], which suggests that in the case of
the live bacteria, an extreme case of toroidal pores could be the
cause of the isotropic 31P NMR signal. However, since model
membranes are used more generally [25], it is difficult to draw
definitive conclusions from one NMR study using live bacteria.
5. Surface activity of antibacterial peptides-monolayer
studies
Surface interactions of the peptides with lipids have been
studied using the Langmuir monolayer method [26]. Applica-
tion of lateral pressure to a monolayer established at the air/
water interface of a water trough reports on the surface
properties of the monolayer material. Once the monolayer is
compressed to a critical point, the monolayer collapses [27].
The collapse pressure point (Πc) is a measure of the ability of
the system to resist compression and hence is related to the
stability of the monolayer. Changes in Πc upon lipid/peptide
mixing are interpreted as a measure of the stabilizing or
disrupting effect of the peptide on the lipid monolayer. The
effect of the lytic peptide, melittin, on lipid monolayers has been
studied using this technique [28].
Monolayer studies of maculatin and citropin have been used
to assess the interaction of these peptides with the neutral lipid
palmitoyl-oleoyl-phosphatidylcholine (POPC), which is used as
a model for eukaryotic membranes, and the anionic lipid
palmitoyl-oleoyl-phosphatidylglycerol (POPG), as a model of a
bacterial membrane [24]. POPC and POPG monolayers exist in
the liquid expanded phase state at room temperature [29]. When
maculatin or citropin are mixed with the neutral POPC two
separate Πc events are observed, which was interpreted as the
peptide and lipid forming domains in the monolayer. By
contrast, in films with the anionic POPG, the peptides showed
miscible behaviour and may relate to the specific lytic activity of
these peptides in bacterial membranes as opposed to red blood
cells. With the application of lateral stress to pure maculatin
monolayers with a basic subphase, a discontinuity occurs in the
compression isotherm that could be due to a structural
reengagement of the peptide. Interestingly, this was not seen
for citropin and may be due to the proline hinge in maculatin.
6. Orientation of peptides in lipid bilayers
The orientation of a number of antimicrobial peptides in
model membranes has been determined using solid-state
NMR, including KIGAKI [30], MSI-78 [31], LL-37 [32],
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gramicidin S [37], magainin [38], melittin [19] and gramicidin
A [39] (also, see articles within this issue by Bechinger, Hong,
Nomura, Ramamoorthy, Ulrich and co-authors). Solid-state
NMR studies of the interaction of antimicrobial peptides from
Australian tree frogs have been undertaken using model
membranes of the zwitterionic phospholipid, dimyristoyl-
phosphatidylcholine (DMPC) [40,41]. Deuterated DMPC
was used to ascertain the interaction of the peptides with the
lipid acyl chains. The order and dynamics of the lipid
headgroups and alkyl chains were measured by 31P and 2H
solid-state NMR, respectively. Changes were seen in the NMR
spectra of both the headgroup (31P) and alkyl chain regions
(2H) of the lipid molecules upon addition of the peptides to
bicelles or mechanically aligned bilayers of DMPC. Each of
the peptides (aurein 1.2, caerin 1.1, citropin 1.1 and maculatin
1.1) at lipid/peptide molar ratios of 15:1 caused changes to the
chemical shift anisotropy of the headgroup 31P atoms [41].
Also in the case of maculatin 1.1 broadening of the NMR
signal was also observed, due to changes in lipid mobility.
However, the interaction with DMPC is only peripheral and
the lipid bilayer phase was preserved even under high peptide
concentrations.
Furthermore, 15N NMR of specifically labelled peptides in
aligned DMPC bilayers was used in an effort to determine the
orientation of the peptides within the lipid bilayer. When the
bilayer normal is aligned perpendicular to the magnetic field of
the magnet, a single resonance is seen in the 15N spectrum at a
chemical shift consistent with the peptide oriented at approx-
imately the magic angle (54.7°) to the membrane surface [41].
However, a similar chemical shift is found for aurein, the
shortest peptide, when the bilayer normal is aligned parallel to
the direction of the applied magnetic field [40]. Since the 15N
resonance of the peptide appears to have the same chemical shift
when the bilayers are aligned both parallel and perpendicular to
the magnetic field, and the value is close to the isotropic
position, then most likely motional averaging of the 15N signal
is taking place. Notably for the 15N studies [40,41] cross
polarisation was extremely difficult to achieve, which suggests
that the peptides are highly mobile. In addition, since the 31P
and 2H spectra, were consistent with a fluid phase lipid bilayer
with little effect of peptides at relatively high concentrations, the
data were taken to show that the peptides do not appear to
interact significantly with zwitterionic lipids.
Attenuated total reflectance-Fourier transform infrared
spectroscopy (ATR-FTIR) was used previously to determine
the insertion of maculatin 1.1 into DMPC and DMPG
membranes [24]. Moreover, deuterium exchange results
showed that the peptide has a preference for the anionic lipids.
In zwitterionic lipids, around 5% of the peptide residues were
protected, whereas 70% of the residues were protected from
exchange by DMPG lipids. ATR-FTIR also gives an estimation
of the angle that the peptide inserts into the membrane. The
angle of the helix axis of maculatin in DMPG membranes was
determined to be 27°–35° relative to the bilayer normal. Such
an angle would suggest that maculatin may be pore-forming in
bacterial membranes. Further, a similar angle of insertion wasobserved for the small percentage of the peptide that entered the
DMPC membranes. This result is consistent with the angle
determined by NMR for the peptide in DMPC bilayers and by
oriented CD measurements [41]. However, both the aligned
NMR and CD studies were carried out in conditions without
excess water, which could favour insertion of the peptide into
the bilayer. These results are consistent with the observation that
maculatin 1.1 lyses bacterial cells at much lower concentrations
than red blood cells [2]. For the ATR-FTIR, the peptide was
added after DMPC/DMPG membrane formation whereas for
the NMR experiments, maculatin was reconstituted with
DMPC, which would promote peptide incorporation. However,
despite the sample conditions favouring insertion, the peptide
showed little preference for neutral membranes.
7. Membrane lysis-fluorescence studies
Fluorescence spectroscopy has been used to determine the
lytic concentrations of membrane perturbing peptides, such as
melittin [42]. This technique was applied to aurein 1.2, citropin
1.1, maculatin 1.1 and two single point mutants of maculatin,
where the proline residue is replaced by alanine or glycine [43].
Concentrations of peptide required to cause leakage from large
(LUV) and giant unilamellar vesicles (GUV) were determined.
The vesicles were formed from POPC and mixed POPC/POPG
(1:1, molar). Maculatin and the derived peptides showed similar
levels of lytic activity in zwitterionic LUV. However, when Pro-
15 is replaced by Gly or Ala, the lytic potency is reduced ten
fold in anionic vesicles. This suggests that proline in maculatin
may play a key role in the antibacterial activity, allowing the
peptide to adopt an optimal amphiphilic conformation at the
interface leading to membrane damage.
A novel method of determining the mechanism by which
antibacterial peptides lyse model membranes was used to study
leakage of two differently sized fluorescent molecules (Alexa488-
dextran, Mw 10 kDa; Alexa
546-maleimide, Mw 1.3 kDa) from
GUV [43]. GUV are completely destroyed by addition of the
shorter sequence peptides, citropin and aurein, and in contrast to
the maculatin peptides, a high peptide to lipid ratio is needed to
achieve dye leakage. Addition of maculatin peptides caused
differential quenching of the two fluorescence probes indicating
that these peptides form pores though which the smaller probe is
able to escape from theGUV.The technique appears to distinguish
between twomodels of lytic action of antimicrobial peptides. The
difference in peptide length may be the origin of the distinction
because the longer peptides are able to adopt a transbilayer
configuration, leading to oligomerization and formation of a pore
while the bilayer character is preserved. The shorter sequence
peptides interact with the membrane but due to a mismatch
between the peptide length and the bilayer thickness, the ‘carpet’
mechanism leads to membrane destabilization.
The fluorescent dye results for native maculatin showing
similar behaviour in POPC and POPC/POPG vesicles contrast
somewhat to the ATR-FTIR in DMPC and DMPG bilayers [24]
and results with POPC and POPG monolayers [26], which
indicate a preference for the anionic lipids. Further work is
needed to explore these differences obtained using a saturated
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(POPC, POPG) monolayer. Evaluation of cell lysis based on
peptide fluorospectroscopy [14] is another avenue that has not
been explored due to the lack of a fluorescent residue (Table 1),
and use of peptides with Trp substitutions may yield useful
insights.
8. Concluding remarks
The lytic activity of antibiotic peptides from Australian tree
frogs, aurein 1.2, citropin 1.1 andmaculatin 1.1, appear to adhere
to the so-called carpet model for the shorter peptides and the
pore-forming model for the longer peptide, maculatin, However,
maculatin may exhibit different lytic mechanisms depending on
the model membrane systems and it remains to further explore
the effect of cholesterol and non-bilayer forming phospholipids
such as phosphatidylethanolamine on the activity of these
antimicrobial peptides. Better model systems are required to
understand the mode of action. Different mechanisms may be at
work resulting in the formation of an isotropic signal in the 31P
NMR spectrum of live bacteria [23] and the escape of small
molecules from GUV [43].
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